Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Sunil Rao, MD a cardiologist at NYU Langone Health, answers various heart-related questions from the internet. He discusses what heart rate is considered too high, the reasons behind…
Robert Moore, MD addresses a viewer’s question about correcting severe ankle deformation caused by long-term steroid use for rheumatoid arthritis. He explains that rheumatoid arthritis, unlike osteoarthritis, involves…
This video discusses the risk factors for IgA nephropathy, a disease with no single known cause. While anyone can develop it, certain groups are at higher risk, including…
Join Payel Gupta, MD an experienced allergist and immunologist, in this insightful interview where she answers 73 questions about her journey in medicine. Learn about her educational background,…
Medicosis Perfectionalis dives into renal cell carcinoma (RCC), a type of kidney cancer. The tutorial covers RCC’s origins in proximal renal tubular cells, the most common subtype (clear…
Osteoarthritis and rheumatoid arthritis are two distinct conditions with similar symptoms, such as joint pain, stiffness, and swelling. Osteoarthritis is a mechanical condition, often seen in older adults,…
This video features a presentation at the Best of Lung 2023 conference. Jaime Schneider, MD discusses the latest advancements in targeted therapies for lung cancer. They highlight the…
Watch the second day of the fourth annual Enco Alert Colloquium, a collaboration with top oncology societies. This event features leading experts discussing the latest in thoracic oncology…
Sean Hashmi, MD, a board-certified nephrologist and obesity medicine specialist, for his weekly Friday night live sessions from Los Angeles. In this episode, Dr. Hashmi delves into IgA…
Dr. Nicolas Girard, MD, PhD, explores new treatments for advanced HER2-positive non-small cell lung cancer (NSCLC). Highlighting the challenges faced by this orphan patient group, he discusses the…
